Improving cancer radiotherapy with 2-deoxy-D-glucose: Phase I/II clinical trials on human cerebral gliomas

International Journal of Radiation Oncology Biology Physics

Volumn 35, Issue 1, 1996, Pages 103-111

  Mohanti, Bidhu K ^f   Rath, Goura K ^f   Anantha, Naranappa ^a,c   Kannan, V ^a,c   Das, Bhabani S ^c,e   Chandramouli, Bangalore A R ^c,e   Banerjee, Ajit K ^f   Das, Sarala ^c   Jena, Amarnath ^b,d   Ravichandran, Ramamurthy ^a,c   Sahi, Uday P ^f   Kumar, Rajinder ^f   Kapoor, Neeru ^c,d   Kalia, Vijay K ^c,e   Dwarakanath, Bilikere S ^b,d   Jain, Viney ^b,d  

^a KIDWAI MEMORIAL INSTITUTE OF ONCOLOGY   (India)

^b INSTITUTE OF NUCLEAR MEDICINE AND ALLIED SCIENCES   (India)

^c Department of Radiotherapy ^*  (India)

^d NMR Research Centre   (India)

^e NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

^f ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

2 Deoxy D glucose; Cerebral gliomas; Radiotherapy

Indexed keywords

DEOXYGLUCOSE; FUROSEMIDE; MANNITOL; METOCLOPRAMIDE; NITROSOUREA; STEROID;

ADULT; ARTICLE; BRAIN DECOMPRESSION; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; COBALT THERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DRUG BLOOD LEVEL; DRUG HALF LIFE; FEMALE; GASTROINTESTINAL SYMPTOM; GLIOBLASTOMA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; ORAL DRUG ADMINISTRATION; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL;

EID: 0030009250     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(96)85017-6     Document Type: Article

References (66)

1. Alexander, E., III. Glioblastoma revisited: Do clinical observations match basic science theory. J. Neurooncol. 17:169-173; 1993.
2. Allalunis-Turner, M. J.; Day, R. S.; Pearcey, R. G.; Urtasun, R. C. Radiosensitivity testing in gynecological tumors and malignant gliomas. In: Dewey, W. C.; Edington, M.; Michael Fry, R. J.; Hall, E. J.; Whitmore, G. F., eds. Radiation 4esearch, vol. II. Toronto: Taylor and Francis; 1992:712-715.
3. Bachelard, H. S. Glucose transport and phosphorylation in cerebral and cerebellar preparations in vitro. In: Rodnight, R.; Bachelard, H. S.; Stahl, W. S., eds. Chemisms of the brain. London: Churchill Livingstone; 1981:2-11.
4. Barton, M. Tables of equivalent dose in 2 Gy fractions: A simple application of the linear quadratic formula. Int. J. Radiat. Radiat. Oncol. Biol. Phys. 31:371-378; 1995.
5. Bernstien, M.; Rutka, J. Brain tumor protocols in North America. J. Neurooncol. 17:231-251; 1993.
6. Bigner, D. D. Biology of gliomas: Potential clinical implications of glioma cell heterogeneity. Neurosurgery 9:320-328; 1981.
7. Blecher, M. A fluorometric method for the determination of 2-deoxy-D-glucose. Anal. Biochem. 2:30-38; 1961.
8. Bleehan, N. M.; Wiltshire, C. R.; Plowman, P. N.; Watson, J. V.; Gleave, J. R. W.; Holmes, A. E.; Treip, C. S.; Hawkins, T. D. A randomized study of misonidazole and radiotherapy for grade III and IV cerebral astrocytoma. Br. J. Cancer 43:436-442; 1981.
9. Burger, P. C.; Mahley, M. S.; Dudka, L.; Vogel, G. S. Morphological effects of radiation administration therapeutically for intracranial gliomas. A postmortem study of 25 cases. Cancer 44:1256-1272; 1979.
10. Calkins, J. Alternative repair models capable of generating shouldered dose-response curves. Int. J. Radiat. Biol. 59:997-999; 1991.
11. Constine, L. S.; Kouski, A.; Ekholm, S.; McDonald, S.; Rubin, P. Adverse effects of brain irradiation correlated with MR and CT imaging. Int. J. Radiat. Oncol. Biol. Phys. 15:319-330; 1988.
12. Curnes, J. T.; Laster, D. W.; Ball, M. R.; Moody, D. M.; Witkofski, R. L. Magnetic resonance imaging of radiation injury to the brain. Am. J. Neuroradiol. 7:389-394; 1986.
13. Curran, W. J., Jr.; Scott, C. B.; Horton, J. Recursive partioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J. Natl. Cancer Inst. 85:704-710; 1993.
14. De Angus, L. M.; Delattre, J. Y.; Radiation induced dementia in patients cured of brain metastasis. Neurology 39:789-796; 1989.
15. Deen, D. F.; Chiarodo, A.; Grimm, E. A.; Fike, J. R.; Asrael, M. A.; Kun, L. E.; Levin, V. A.; Marton, L. J.; Packer, R. L.; Pegg, A. E. Brain tumor working group report on the 9th International conference on Brain Tumor Research and Therapy. J. Neurooncol. 16:243-272; 1993.
16. DiChiro, G.; Brooks, R. A.; Patronas, N. T.; Bairamain, D.; Kornblith, P. L.; Smith, B. H.; Mansi, L.; Barker, J. Issues in the in vivo measurement of glucose metabolism of human central nervous system tumors. Ann. Neurol. Suppl. 15:S138-S146; 1984.
17. Dwarakanath, B. S.; Jain, V. K. Modification of the radiation induced damage by 2-deoxy-D-glucose in organ cultures of human cerebral gliomas. Int. J. Radiat. Oncol. Biol. Phys. 13:741-746; 1987.
18. Dwarakanath, B. S.; Jain, V. K. Energy linked modifications of the radiation response in a human cerebral glioma cell line. Int. J. Radiat. Oncol. Biol. Phys. 17:1033-1040; 1989.
19. Dwarakanath, B. S.; Jain, V. Effects of gamma-rays and glucose analogs on the energy metabolism of a cell line derived from human cerebral glioma. Ind. J. Biochem. Biophys. 28:203-209; 1991.
20. Dwarakanath, B. S.; Manogaran, P. S.; Das Sarala; Das, B. S.; Jain, V. Heterogeneity in DNA content and proliferative status of human brain tumors. Ind. J. Med. Res 100:279-286; 1994.
21. Fertil, B.; Malaise, E. P. Inherent cellular radiosensitivity as a basic concept for human radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 7:621-629; 1981.
22. Fike, J. R.; Cann, C. E.; Turowski, K.; Higgins, R. J.; Chan, A. S.; Phillips, T. L.; Davis, R. L. Radiation dose response of normal brain. Int. J. Radiat. Oncol. Biol. Phys. 14:63-70; 1988.
23. Garcia, D. N.; Fulling, K. H.; Marks, J. E. The value of radiation therapy in addition to surgery for astrocytoma of the adult cerebrum. Cancer 55:919-927; 1985.
24. Glinski, B. Postoperative hypofractionated radiotherapy vs. conventionally fractionated radiotherapy in malignant gliomas.: A preliminary report on a randomized trial. J. Neurooncol. 16:167-172; 1993.
25. Heller, D. P.; Raaphorst, G. P. The kinetics of cellular recovery in exponential and plateau growth phase human glioma cells following gamma irradiation. Int. J. Radiat. Oncol. Biol. Phys. 30:383-390; 1994.
26. Jain, V. K.; Gupta, I.; Lata, K. Energetics of cellular repair processes in a respiratory deficient mutant of yeast. Radiat. Res. 92:463-473; 1982.
27. Jain, V. K.; Holtz, G. W.; Pohlit, W.; Purohit, S. C. Inhibition of unscheduled DNA synthesis and repair of potentially lethal X-ray damage by 2-deoxy-D-glucose in yeast. Int. J. Radiat. Biol. 32:175-180; 1977.
28. Jain, V.; Kalia, V.; Dwarakanath, B. S.; Singh, S. P. Modification of repair processes for improving tumor radiotherapy. In: Jain, V.; Goel, H.; Pohlit, W., eds. Recent advances in radiation oncology. New Delhi: ICMR; 1990:103-121.
29. Jain, V. K.; Kalia, V. K.; Gopinath, P. M.; Naqvi, S.; Kucheria, K. Optimization of cancer therapy: Part III - Effects of combining 2-deoxy-D-glucose treatment with gamma irradiation on normal mice. Ind. J. Exp. Biol. 17:1320-1325; 1979.
30. Jain, V. K.; Kalia, V. K.; Sharma, R.; Maharajan, V.; Menon, M. Effects of 2-deoxy-D-glucose on glycolysis, proliferation kinetics and radiation response of human cancer cells. Int. J. Radiat. Oncol. Biol. Phys. 11:943-950; 1985.
31. Jain, V. K.; Pohlit, W. Biocybernetics of cancer - Optimization of cancer therapy with ionizing radiations. Report on an Indo-German joint research project. New Delhi, India: ICMR; 1986:1-207.
32. Jain, V. K.; Pohlit, W. Influence of energy metabolism on the repair of x-ray damage in living cells. III. Effect of 2-deoxy-D-glucose on liquid holding reactivation in yeast. Biophysik 10:137-142; 1973.
33. Jain, V. K.; Porschen, E.; Feinendegen, L. E. Optimization of cancer therapy. Part II - Effects of combining 2-deoxy-D-glucose treatment with gamma irradiation on Sarcoma-180. Ind. J. Exp. Biol. 15:714-718; 1977.
34. Jha, B.; Pohlit, W. Reversibility of inhibition of DNA double strand break repair by 2-deoxy-D-glucose in Ehrlich ascites tumour cells. Int. J. Radiat. Biol. 63:459-467; 1993.
35. Kalia, V. K.; Jain, V. K.; Otto, F. J. Optimization of cancer therapy: Part IV - Effects of 2-deoxy-D-glucose on radiation-induced chromosomal damage in PHA stimulated peripheral leukocytes. Ind. J. Exp. Biol. 20:884-888; 1982.
36. Kaplan, R. S. Supratentorial malignant gliomas: Risk patterns and therapy. J. Natl. Cancer Inst. 85:690-691; 1993.
37. Kasid, U.; Pirollo, K.; Dritschilo, A.; Chang, E. Oncogenic basis of radiation resistance. Adv. Cancer. Res. 61:195-233; 1993.
38. Kretzchmar, K.; Schicketanz, K. H. Measurements of the volume and density of intracerebral tumors by CT following therapy. Neuroradiology 23:175-184; 1982.
39. Landau, B. R.; Laszlo, J.; Stengle, J.; Burk, D. Certain metabolic and pharmacological effects in cancer patients given infusions of 2-deoxy-D-glucose. J. Natl. Cancer Inst. 21:485-494; 1958.
40. Leith, J. T.; Schilling, W. A.; Wheeler, K. T. Cellular radiosensitivity of a rat brain tumor. Cancer 35:1545-1548; 1975.
41. Marks, J. E. Radiation treatment of brain tumors: Concepts and strategies. Crit. Rev. Neurobiol. 5:93-112; 1989.
42. Marks, J. E.; Baglan, R. J.; Wong, J. Radiation damage to brain and cranial soft tissues: Outcome and incidence before and after reduction in dose. In: Walker, M. D.; Thomas, D. G. T., eds. Biology of brain tumors. The Hague: Martinus Nijhoff; 1986:325-348.
43. Matsudaria, H.; Furuno, I.; Otsuka, H. Possible requirements of adenosine triphosphate for the rejoining of x-ray induced breaks in the DNA of Ehrlich ascites tumor cells. Int. J. Radiat. Biol. 17:339-347; 1970.
44. Mohanti, B. K.; Rath, G. K.; Banarjee, A. K.; Sahi, U. P.; Kumar, R.; Jena, A.; Kashyap, R.; Kapoor, N.; Jain, V. Improving cancer radiotherapy with 2-DG: Phase II clinical trial on human cerebral gliomas. XVI International cancer congress, vol. I; 1994:47.
45. Naqvi, S.; Joshi, K. N.; Basu, A. K.; Jain, V. K. Optimizing cancer therapy - Studies on the combination of 131-I with 2-deoxy-D-glucose in the treatment of thyroid cancer. Bombay, India: Abstr. VI Ann. Conf. Soc. Nucl. Med.; 1974:3.
46. Nelson, D. F.; Diener-West, M.; Weomstein, A. S.; Schoenfeld, D.; Nelsin, J. S.; Sause, W. T.; Chang, C. H.; Goodmen, R.; Carabell, S. A randomized comparison of misonidazole sensitized radiotherapy plus BCNU and radiotherapy plus BCNU for treatment of malignant gliomas after surgery. Final report of a RTOG study. Int. J. Radiat. Oncol. Biol. Phys. 12:1793-1800; 1986.
47. Nordman, E. Evolution of modern radiotherapy in the treatment of gliomas. In: Karim, A. B. M. F.; Laws, E. R., Jr., eds. Glioma, principles and practice in neuro-oncology. Berlin: Springer Verlag; 1991:107-120.
48. Purohit, S. C.; Pohlit, W. Experimental evaluation of the glucose antimetabolite, 2-deoxy-D-glucose (2-DG) as a possible adjuvant to radiotherapy of tumors. I. Kinetics of growth and survival of Ehrlich ascites tumor cells (EATC) in vitro and of growth of solid tumors after 2-DG and X-irradiation. Int. J. Radiat. Oncol. Biol. Phys. 8:495-499; 1982.
49. Ross, G. M.; McIlwrath, A.; Brown, R. Molecular determinants of radioresistance in human glioma. J. Neurooncol. 21:46; 1994.
50. Salazar, O. M.; Rubin, P.; Feldstein, M. L.; Pizzutiello, R. High dose radiation therapy in the treatment of malignant gliomas: Final report. Int. J. Radiat. Oncol. Biol. Phys. 5:1733-1740; 1979.
51. Salcman, M.; Scholtz, H.; Kaplan, R. S.; Kulik, S. Long term survival in patients with malignant astrocytoma. Neurosurgery 34:213-220; 1994.
52. Shapiro, J. R. Biology of gliomas: Heterogeneity, oncogenes, growth factors. Semin. Oncol. 13:4-16; 1986.
53. Sheline, G. E. Radiotherapy of adult primary cerebral neoplasms. In: Walker, M. D., ed. Oncology of the nervous system. Boston: Martinus Nijhoff; 1983:223-245.
54. Singh, S. P.; Singh, S.; Jain, V. Effects of 5-bromo-2-deoxy uridine and 2-deoxy-D-glucose on radiation-induced micronuclei in mouse bone marrow. Int. J. Radiat. Biol. 58:791-797; 1990.
55. Somogyi, N. Notes on sugar determination. J. Biol. Chem. 195:19-23; 1952.
56. Suit, H. D.; Baumann, M.; Skates, S.; Convery, K. Clinical interest in determinations of cellular radiation sensitivity. Int. J. Radiat. Biol. 56:725-737; 1989.
57. Sutton, M. L. Adult central nervous system. In: Pointon, R. C. S., ed. The radiotherapy of malignant disease. 2nd ed. Great Britain: Springer Verlag; 1991:207-234.
58. Taghian, A.; Suit, H.; Pardo, F.; Gioioso, D.; Tomkinson, K.; duBois, W.; Gerweck, L. In vitro intrinsic radiation sensitivity of glioblastoma multiforme. Int. J. Radiat. Oncol. Biol. Phys. 23:55-62; 1992.
59. Tamura, M.; Nakamura, M.; Kunimine, H.; Ono, N.; Zama, A.; Hayakawa, K.; Niibe, H. Large dose fraction radiotherapy in the treatment of glioblastoma. J. Neurooncol. 7:113-119; 1989.
60. Timperley, W. R. Glycolysis in neuroectodermal tumours. In: Thomas. D. G. T.; Graham, D. I., eds. Brain tumors - Scientific basis, clinical investigation and current therapy. London: Butterworths; 1980:145-167.
61. Verma, A.; Sharma, R.; Jain, V. K. Energetics of DNA repair in UV irradiated peripheral blood leukocytes from chronic myeloid leukaemia patients. Photochem. Photobiol. 36:627-632; 1982.
62. Warburg, O. On the origin of cancer cells. Science 123:309-314; 1956.
63. Weichselbaum, R. R.; Beckett, M. A.; Schwartz, J. L.; Dritschilo, A. Radioresistant tumour cells are present in head and neck carcinomas that recur after irradiation. Int. J. Radiat. Oncol. Biol. Phys. 15:575-579; 1988.
64. Yang, X.; Darling, J. L.; McMillan, T. J.; Peacock, J. H.; Steel, G. G. Radiosensitivity, recovery and dose rate effect in three human glioma cell lines. Radiother. Oncol. 19:49-56; 1990.
65. Zimmerman, R. D.; Fleming, C. A.; Lee, B. C.; Saint-Louis, L. A.; Deck, M. D. Periventricular hyperintensity as seen by magnetic resonance: Prevalence and significance,. Am. J. Reentgenol. 146:443-459; 1986.
66. Zulch, K. J. Principles of the new World Health Organization (WHO) classification of brain tumors. Neuroradiology 19:59-70; 1980.